Pricing Log in Create free account
Saturday 17 October 2026 Export BKD’s income statement to Excel — free account

Brookdale Senior Living Inc.

BKD Healthcare Medical Care Facilities

Brookdale Senior Living Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 2.19% from fiscal 2024. In the quarter to June 2026, revenue fell 11.6%, EPS grew 155.6%, free cash flow grew 533.1% and total debt was flat, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

10.05 0.04 −0.40%
Market cap
$2.4B
P/E
0.0×
Fwd P/E
−68.3×
Dividend yield
—
F-score
5/9
Altman Z
−0.22
Beneish M
−2.63
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 9.20%

Capital & Financial Ratios $m

Market Cap 2,410.00
Revenue 3,050.70
Net Income (138.36)
Free Cash Flow (140.98)
Net Debt 3,895.85
Current Ratio 1.14
Debt/Equity (156.38) (negative: negative equity)
P/E ratio 0.00
Fwd P/E (68.30) (negative: loss-making)
P/S ratio 0.79
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth 102.68% (at or above 15%: strong)
Next Y EPS Growth 472.22% (at or above 15%: strong)
Next Y revenue growth (8.27%) (below 0%: weak)
Next 5Y EPS Growth 45.59% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 2.1×, against a ten-year median of 1.6×; over the ten years it ranged from 1.1× in 2020 to 2.5× in 2026.
P/S against its own 10 years 92.08%
10-year low 10-year high
EV/Sales against its own 10 years 92.74%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 349 369 312 424
Receivables 48 52 68 56
Inventory — — — —
Other — — 77 24
478 513 554 597
2023 2024 2025 Q'26
Payables 67 66 75 83
ST’ Debt 41 41 77 71
Other 56 61 66 60
600 580 568 522

Compound Annual Growth %

10y 5y 3y
Sales (4.31%) (2.04%) 4.17%
Cash Flow (2.89%) 1.18% 305.05%
Earnings 0.00% 0.00% 0.00%
Book Value 0.00% 0.00% 0.00%

Revenue $m

Mar Jun Sep Dec Year
’26 765 719 — — —
’25 814 813 813 754 3,194
’24 783 778 784 781 3,125
’23 753 751 757 754 3,016
’22 678 690 757 701 2,825
’21 749 723 642 644 2,758
’20 1,014 866 808 852 3,540
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 21 92 — — —
’25 23 84 77 35 218
’24 (1) 56 66 45 166
’23 24 64 46 29 163
’22 (23) 12 64 (49) 3
’21 (24) 3 7 (81) (95)
’20 57 152 (77) 73 206
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (26) 191 — — —
’25 (18) 30 34 (340) (295)
’24 (45) 3 11 (114) (143)
’23 (26) 3 24 (72) (71)
’22 (63) (45) 10 (95) (194)
’21 (64) (36) (39) (132) (271)
’20 (12) (338) (131) 501 20
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (0.03) 0.10 — — —
’25 (0.28) (0.18) (0.48) (0.17) (1.12)
’24 (0.13) (0.17) (0.22) (0.37) (0.89)
’23 (0.20) (0.02) (0.22) (0.40) (0.84)
’22 (0.54) (0.45) (0.15) (0.13) (1.25)
’21 (0.59) (0.45) 0.89 (0.44) (0.54)
’20 2.00 (0.65) (0.68) (0.24) 0.44
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 10.65 8.78 6.08 5.97 1.47 4.15 2.61 2.27 4.89 4.45

Analyst estimates 2026–2028

Powerpack
High 19.71 16.31 10.39 8.80 8.57 8.95 7.61 6.11 8.12 11.38
People
People Employees 77,600 75,600 65,400 58,400 — — — — — —
Revenue/emp, $m 0.06 0.06 0.07 0.07 0.00 0.00 0.00 0.00 0.00 0.00
Income, $m
Income, $m Revenue 4,977 4,747 4,531 4,057 3,540 2,758 2,825 3,016 3,125 3,194
Gross margin, % 43.75 45.18 45.86 41.08 33.85 24.74 26.25 29.38 30.15 30.62
EBT (399) (588) (578) (271) 87 (108) (240) (180) (197) (265)
EBT margin, % (8.02) (12.39) (12.75) (6.67) 2.47 (3.90) (8.49) (5.98) (6.31) (8.29)
Net income (405) (572) (528) (268) 82 (99) (238) (189) (202) (263)
Depreciation 770 897 450 382 363 343 352 350 368 370
Per share, $
Per share, $ Revenue 26.81 25.50 24.17 21.82 19.29 14.91 14.83 13.39 13.74 13.58
Earnings (2.18) (3.07) (2.82) (1.44) 0.45 (0.54) (1.25) (0.84) (0.89) (1.12)
Cash flow 2.01 2.03 1.09 1.16 1.12 (0.51) 0.02 0.72 0.73 0.93
Capex (1.80) (1.15) (1.20) (1.64) (1.01) (0.95) (1.03) (1.04) (1.36) (2.18)
Free cash flow 0.22 0.88 (0.11) (0.47) 0.11 (1.47) (1.02) (0.31) (0.63) (1.25)
Book value 11.19 8.22 5.43 3.76 4.37 3.78 3.07 1.80 0.94 (0.18)
Shares, m 186 186 187 186 183 185 190 225 228 235
Valuation, ×
Valuation, × P/E 0.00 0.00 0.00 0.00 10.07 0.00 0.00 0.00 0.00 0.00
P/S 0.48 0.40 0.28 0.33 0.23 0.35 0.19 0.43 0.37 0.79
P/B 1.14 1.24 1.23 1.93 1.01 1.36 0.90 3.18 5.35 0.00
EV/Sales 1.63 1.34 1.17 1.32 1.33 1.73 1.46 1.59 1.63 2.05
EV/FCF (45.55) 38.78 (246.69) (60.59) 237.20 (17.59) (21.29) (67.56) (35.58) (22.21)
Cash, $m
Cash, $m Operating cash flow 374 378 204 216 206 (95) 3 163 166 218
Capex (334) (214) (225) (305) (186) (177) (197) (234) (310) (513)
Free cash flow 40 164 (22) (88) 20 (271) (194) (71) (143) (295)
Balance, $m
Balance, $m Working capital (112) (194) 1 (451) 83 67 (4) (122) (67) (14)
Total debt 5,976 5,035 4,492 4,327 4,460 4,373 4,075 3,848 4,330 4,317
Net debt 5,726 4,484 4,051 3,991 3,878 3,817 3,600 3,499 3,961 4,005
Shareholders’ equity 2,078 1,530 1,018 699 803 700 584 405 214 (43)
Returns, %
Returns, % ROA (4.20) (6.77) (7.47) (3.92) 1.16 (1.49) (3.86) (3.28) (3.39) (4.28)
ROIC (0.25) (2.81) (7.33) (0.59) (1.30) (3.00) (0.64) 0.29 0.70 0.21
ROE (17.83) (31.67) (41.45) (31.21) 10.93 (13.22) (37.14) (38.21) (65.24) (308.09)
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Brookdale Senior Living Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ACHC Acadia Healthcare Company, Inc. $2.9B — (loss-making) 21.1× −0.39% (below 0%: shrinking) −63.64% (below 0%: shrinking) +856.54% (above 0%: growing) 100.00% 10.14% Compare
AVAH Aveanna Healthcare Holdings Inc. $2.8B 9.5× 10.4× +13.73% (above 0%: growing) +46.15% (above 0%: growing) +57.89% (above 0%: growing) 32.59% 11.93% Compare
GRDN Guardian Pharmacy Services, Inc. $2.5B 37.5× 39.5× +2.16% (above 0%: growing) +133.33% (above 0%: growing) +60.83% (above 0%: growing) 22.75% 5.87% Compare
BKD Brookdale Senior Living Inc. $2.4B — (loss-making) — (loss-making) −11.61% (below 0%: shrinking) n/m +533.14% (above 0%: growing) 29.94% 11.86%
MD Pediatrix Medical Group, Inc. $2.3B 13.1× 11.3× +4.04% (above 0%: growing) +6.52% (above 0%: growing) −6.56% (below 0%: shrinking) 27.16% 11.67% Compare
ADUS Addus HomeCare Corporation $2.2B 20.4× 14.9× +8.01% (above 0%: growing) +24.17% (above 0%: growing) +81.74% (above 0%: growing) 32.21% 10.32% Compare
SGRY Surgery Partners, Inc. $1.9B — (loss-making) — (loss-making) +2.75% (above 0%: growing) n/m −60.63% (below 0%: shrinking) 22.41% 12.78% Compare
ASTH Astrana Health, Inc. $1.9B 44.3× 29.7× +48.52% (above 0%: growing) +110.53% (above 0%: growing) −67.74% (below 0%: shrinking) 10.70% 3.53% Compare
ARDT Ardent Health, Inc. $1.7B 21.7× 7.7× −1.40% (below 0%: shrinking) −76.92% (below 0%: shrinking) +121.70% (above 0%: growing) 100.00% 3.44% Compare
Median of peers $2.2B 21.0× 14.9× +3.40% +24.17% +59.36% 29.69% 10.23%

All 55 Medical Care Facilities stocks →

Brookdale Senior Living Inc. (BKD) key facts

  • Concern: Brookdale Senior Living Inc. reported a net loss of $262.7 million, or a loss of $1.12 per share, for fiscal 2025.
  • Strength: Brookdale Senior Living Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 2.19% from fiscal 2024.
  • Brookdale Senior Living Inc. (BKD) is a Medical Care Facilities company in the Healthcare sector, listed on the New York Stock Exchange.
  • As of October 16, 2026, BKD traded at $10.05, a market capitalization of $2.4 billion.
  • Trailing earnings are negative, so a P/E ratio is not meaningful; the stock trades at 0.8× sales.
  • Return on equity was −308.1% and debt-to-equity -156.38.
  • Its Piotroski F-score is 5 out of 9 and its Altman Z-score is −0.22 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Brookdale Senior Living Inc. (BKD) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/BKD · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com